5WT9
Complex structure of PD-1 and nivolumab-Fab
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SSRF BEAMLINE BL17U |
Synchrotron site | SSRF |
Beamline | BL17U |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2016-07-13 |
Detector | ADSC QUANTUM 315r |
Wavelength(s) | 0.97907 |
Spacegroup name | P 43 21 2 |
Unit cell lengths | 108.527, 108.527, 145.423 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 37.100 - 2.401 |
R-factor | 0.189 |
Rwork | 0.187 |
R-free | 0.22780 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 3eyq |
RMSD bond length | 0.011 |
RMSD bond angle | 1.218 |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | PHASER |
Refinement software | PHENIX ((1.10.1_2155)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 50.000 | 2.490 |
High resolution limit [Å] | 2.400 | 2.400 |
Number of reflections | 34630 | |
<I/σ(I)> | 32.1 | |
Completeness [%] | 100.0 | |
Redundancy | 21.7 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 5.5 | 277 | 0.2M Ammonium acetate, 0.1 M BIS-TRIS pH5.5, 25% w/v Polyethylene glycol 3350 |